Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.00
Bid: 53.00
Ask: 55.00
Change: -0.20 (-0.38%)
Spread: 2.00 (3.774%)
Open: 54.00
High: 54.00
Low: 52.80
Prev. Close: 53.00
SDI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading & COVID-19 Update

23 Apr 2020 07:00

RNS Number : 5656K
SDI Group PLC
23 April 2020
 

SDI Group plc

 

("SDI", the "Company" or the "Group")

(AIM: SDI)

 

Trading Update

COVID-19 Update

 

SDI Group plc, the AIM quoted Group focused on the design and manufacture of scientific and technology products for use in digital imaging and sensing control applications, is pleased to announce an update on trading for the year ending 30 April 2020, and on the impact of COVID-19 on SDI's operations.

 

The Group has a diversified portfolio of companies and since the announcement of a UK "lockdown" on 23 March has continued to operate at all eight of its operating units. The Group continues to expect to meet market profit expectations for the year ending 30 April 2020, with sales of around £24 million.

 

During the period, the Company has taken steps in order to:

- protect the health and wellbeing of our employees;

- reduce business costs as appropriate making use of US and UK Government programmes, whilst still maintaining our capabilities in the short and the long term;

- conserve cash and liquidity;

- support customers in medical and scientific areas that require critical products for the national interest and for the global effort against COVID-19.

 

Employees

We have taken all necessary steps to protect the health of our employees, clients and suppliers. Protocols have been introduced in the workplace and, where possible, staff are now working from home. The Board is extremely proud of the way the Group's employees have reacted to the crisis and is grateful to them and their families.

 

Reducing Costs

Since 23 March, the Group has been actively reducing SDI's overall costs. These include a cut in all SDI board salaries and fees of 33% for a period of three months. The Group has also, where required, furloughed staff with Government support, ensuring the retention of our staff for the future. 19% of SDI staff are currently furloughed and no staff members have been made redundant.

 

Cash and Liquidity

SDI has a strong balance sheet with current cash in excess of £4.5m, unused debt facilities of £0.6m and bank debt of £8.9m. The Group has a good long-term relationship with its bank and has agreed, as a precautionary measure, a capital repayment holiday of three months of its revolving credit facility. The Group has also taken advantage of the UK Government's scheme allowing a temporary VAT payment deferral.

 

Current Trading and Outlook

The Board expects SDI to report profit for the year to 30 April 2020 in line with market expectations.

 

However due to COVID-19 SDI withdraws market guidance for the year to 30 April 2021. There has been some disruption to supply and some slow-down in orders, but SDI currently has all factories in operation and has so far remained both profitable and cash generative. At least four of our production units are providing their customers with components for medical and scientific products used in the fight against COVID-19.

 

Ken Ford, Chairman of SDI, said:

"The Group expects to report profit for the year to 30 April 2020 in line with market expectations. The Group remains open for business, although due to COVID-19, sales are at reduced levels. Demand for some SDI products has increased and the Group looks forward to being able to grow both organically and through acquisition during the new financial year when conditions permit."

 

 

The Group currently expects to announce final results for the year ended 30 April 2020 in July 2020.

 

Enquiries

SDI Group plc 01223 320480

Ken Ford, Chairman

Mike Creedon, CEO

Jon Abell, CFO

www.scientificdigitalimaging.com

 

finnCap Ltd 020 7220 0500

Ed Frisby/Kate Bannatyne - Corporate Finance

Andrew Burdis/Sunila de Silva - ECM

 

JW Communications 07818 430 877

Julia Wilson - Investor & Public Relations

 

About SDI Group plc:

SDI designs and manufactures scientific and technology products for use in digital imaging and sensing and control applications including life sciences, healthcare, astronomy, manufacturing, precision optics and art conservation. SDI operates through its company divisions: Atik Cameras, Synoptics, Graticules Optics, Sentek, Astles Control Systems, Applied Thermal Control, MPB Industries and Chell Instruments.

 

SDI continues to grow by developing its own technology advancements and by improving its global sales channels, as well as through pursuing strategic, complementary acquisitions.

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPPUBPCUPUGMP
Date   Source Headline
12th Dec 20127:00 amRNSUnaudited Interim Results to 31 October 2012
12th Dec 20127:00 amRNSSynoptics Health: ProReveal product launch update
15th Nov 20124:59 pmRNSHolding(s) in Company
16th Oct 20127:00 amRNSIssue of Equity
11th Sep 20123:20 pmRNSResult of AGM
25th Jul 201212:01 pmRNSDirector/PDMR Shareholding
25th Jul 20128:12 amRNSFinal Results
29th May 201210:05 amRNSDirectorate Change
16th Dec 20117:00 amRNSHalf Yearly Report
15th Sep 20111:52 pmRNSAppointment of Acting Managing Director
1st Sep 20112:04 pmRNSResult of AGM
18th Jul 20115:01 pmRNSNotice of Results
1st Jun 20111:00 pmRNSTrading Update
17th Jan 20117:00 amRNSHalf Yearly Report
10th Dec 20103:48 pmRNSTrading Update
27th Sep 201012:01 pmRNSSector Change
23rd Sep 20103:15 pmRNSResult of AGM
19th Jul 20102:27 pmRNSDirector/PDMR Shareholding
19th Jul 20107:00 amRNSFinal Results
16th Jul 20108:58 amRNSAnalyst Presentation
7th Jul 201012:08 pmRNSNotice of Results
7th Jul 201012:01 pmRNSChange of Adviser
28th Jun 20107:00 amRNSSynbiosis Update
24th May 20107:00 amRNSDirectorate Change
21st May 20107:00 amRNSTrading Update
16th Mar 201012:25 pmRNSDirectorate Changes
2nd Mar 20109:59 amRNSTrading Update
10th Feb 20107:00 amRNSNew Atik Camera
25th Jan 20107:00 amRNSHalf Yearly Report
4th Jan 20104:20 pmRNSDirectorate Change
9th Dec 20091:46 pmRNS12 Months on AIM
21st Oct 200911:21 amRNSResult of AGM
16th Oct 20093:45 pmRNSIssue of Equity
14th Oct 20094:50 pmRNSChange of Adviser
14th Sep 20097:00 amRNSFinal Results
18th Jun 20094:52 pmRNSExercise of Options
7th Apr 20097:00 amRNSTrading Statement
6th Feb 20094:14 pmRNSDirector/PDMR Shareholding
27th Jan 20097:30 amRNSInterim Results
8th Dec 20087:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.